ArticleClinical and molecular hepatology2017

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?

Yun Bin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.